PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER Russian patent published in 2017 - IPC A61K9/52 A61K31/554 A61K31/785 A61P1/12 A61P1/16 

Abstract RU 2619215 C2

FIELD: pharmacology.

SUBSTANCE: group of inventions can be used for the application of the IBAT inhibitor and the bile acid binder (cholestyramine, colestipol, or colesevelam) for preparing the combination for simultaneous, sequential or separate introduction in the treatment of the liver diseases. Herewith the bile acid binder is located in the core and is composed for release in the colon, and the IBAT-inhibitor is located in the outer layer, composed for immediate or delayed release in the distal jejunum or in the proximal ileum. Also the use of the pharmaceutical composition is provided, comprising an IBAT-inhibitor and a bile acid binder for preparing the medicine for the treatment of the liver diseases.

EFFECT: group of inventions provides treatment of the liver diseases.

14 cl, 2 tbl, 20 ex

Similar patents RU2619215C2

Title Year Author Number
IBAT INHIBITOR FOR TREATING HEPATIC DISORDERS 2011
  • Jillberg Per-Jeran
  • Graffner Khans
  • Starke Ingemar
RU2591188C2
BENZOTHIADIAZEPINE DERIVATIVES AND METHOD FOR PRODUCTION THEREOF (VARIANTS) 2002
  • Starke Ingemar
  • Dal'Strum Mikaehl' Ul'F Jukhan
  • Blumberg David
  • Alenfal'K Suzanne
  • Sharet Ture
  • Lemurell' Malin
RU2305681C2
USE OF IBAT INHIBITOR FOR TREATING AND PREVENTING CONSTIPATION 2008
  • Abrakhamsson Khasse Roland
  • Gillberg Per-Goran
RU2482850C2
IBAT ANTIOXIDANT APPLICATION FOR TREATMENT OR PREVENTION OF COPROSTASIA 2004
  • Abrakhamsson Khasse Roland
  • Gillberg Per-Goran
RU2342928C2
BENZOTHIADIAZEPINE DERIVATIVES, METHOD OF THEIR OBTAINING AND APPLICATION, PHARMACEUTICAL COMPOSITION WITH INHIBITION EFFECT ON ILEUM BILE ACID TRANSFER 2003
  • Ingemar Starke
  • Mikaehl' Ul'F Jokhan Dal'Strum
  • Mats Peter Nordberg
  • Sjuzanna Alenfal'K
  • Andreas Krister Vall'Berg
  • Stig Jonas Bostrum
RU2333205C2
METHODS FOR INCREASING HEIGHT OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE 2020
  • Jaecklin, Thomas
  • Dorenbaum, Alejandro
RU2822484C2
DERIVATIVES OF PEPTIDES COMPRISING THIAZEPINE GROUP FOR TREATMENT OF HYPERGLYCEMIC STATES 2003
  • Starke Ingemar
  • Dal'Strom Mikaehl' Ul'F Jokhan
  • Alenfal'K Susanna
  • Sk'Jaret Ture
  • Lemurell' Malin
RU2315772C2
1,5-BENZOTHIAZEPINES AND EMPLOYMENT THEREOF AS ANTIHYPERLIPIDEMIC DRUGS 2001
  • Starke Ingemar
  • Dal'Strom Mikaehl'
  • Blomberg David
RU2302414C2
DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTORS ACTIVATED BY PEROXISOME PROLIFERATOR (PPARα), METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR TREATMENT OF DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2 2002
  • Al'Stermark Lindstedt Ehva-Lotte
  • Ol'Sson Anna Kristina
  • Li Lanna
RU2303031C2
DERIVATIVES OF SUBSTITUTED PHENYLPROPIONIC ACID AS AGONISTS OF HUMAN ALPHA-RECEPTOR (PPARα) ACTIVATED BY PEROXISOME PROLIFERATORS, METHOD AND INTERMEDIATE COMPOUNDS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, THEIR USING AND METHODS FOR DYSLIPIDEMIA TREATMENT AND TYPE 2 DIABETES MELLITUS 2002
  • Al'Stermark Lindstedt Ehva-Lotte
  • Ol'Sson Anna Kristina
  • Li Lanna
RU2300517C2

RU 2 619 215 C2

Authors

Jillberg Per-Jeran

Graffner Khans

Starke Ingemar

Dates

2017-05-12Published

2011-11-08Filed